The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of the cardiovascular risk profile of Ph+ leukemia patients treated with ponatinib.
Hanna Jean Khoury
No relevant relationships to disclose
Jorge E. Cortes
Consultant or Advisory Role - ARIAD; Pfizer; Teva
Research Funding - ARIAD; Bristol-Myers Squibb; ChemGenex; Novartis; Pfizer
Dong-Wook Kim
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb; Novartis; Wyeth
Research Funding - Bristol-Myers Squibb; Novartis; Wyeth
Javier Pinilla-Ibarz
Consultant or Advisory Role - ARIAD
Honoraria - ARIAD
Research Funding - ARIAD
Philipp D. Le Coutre
Honoraria - Bristol-Myers Squibb; Novartis
Ronald Paquette
Honoraria - ARIAD
Charles Chuah
Honoraria - Bristol-Myers Squibb; Novartis
Franck E. Nicolini
Consultant or Advisory Role - ARIAD; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Research Funding - Novartis
Jane Apperley
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Moshe Talpaz
Consultant or Advisory Role - ARIAD
Research Funding - ARIAD
John F. DiPersio
No relevant relationships to disclose
Daniel J. DeAngelo
Consultant or Advisory Role - ARIAD
Elisabetta Abruzzese
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Delphine Rea
Honoraria - Bristol-Myers Squibb; Novartis; Teva
Michele Baccarani
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer; Teva
Martin C. Müller
No relevant relationships to disclose
Carlo Gambacorti-Passerini
No relevant relationships to disclose
Stephanie Lustgarten
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Kumiko Yanase
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Hagop M. Kantarjian
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer